Based on current evidence, GLP-1 microdosing is a complementary approach, not a replacement for standard immunotherapy
En la presentacin del estudio se hizo hincapi en el mantenimiento de la eficacia y seguridad del frmaco agonista dual, aunque el tiempo total no alcanza los dos aos de seguimiento, claramente inferior al mantenimiento de la prdida de peso demostrada con procedimientos como la ciruga baritrica
Alternative therapy, such as hydroxocobalamin, is advised
Whilst mild to moderate gastrointestinal symptoms are expected with Ozempic therapy, certain presentations warrant prompt medical assessment to exclude serious complications or conditions requiring intervention
Pharmacies can prepare tirzepatide at various strengths to optimize needle gauge, injection frequency, and patient experience
This may be due to altered -cell function in diabetic patients, which impairs the efficacy of GLP-1(936)